The Science of Aging

One Process, Five Names

October 22, 2026 7 min read By Naisohn Arfai, MD

Teal topographic contour lines

In the emergency department, you eventually stop seeing separate diseases.

A man arrives at seventy with heart failure. His chart also carries type 2 diabetes, kidney decline, a small stroke from two years ago and the early edges of memory loss. Each condition has its own specialist and its own medications, and the record lists them as five problems that happened to arrive in the same body. Over many years and many nights like that one, I began to see them as one process wearing five names.

The common soil

That intuition now has a science behind it. Geroscience, the field that studies the biology linking aging to disease, begins from an observation so familiar that medicine long treated it as background. Age is the largest single risk factor for nearly every chronic disease we fear, including heart disease, most cancers, type 2 diabetes, kidney disease, stroke and dementia. In 2014, a group of leading researchers set out the case in the journal Cell that these conditions share more than the person who carries them. They grow from the same biological changes, and those changes can be studied, measured and, in principle, slowed.

Researchers describe these changes as the hallmarks of aging. The framework, first published in 2013 and expanded in 2023 to twelve hallmarks, includes damage to DNA, the shortening of the protective caps on our chromosomes, shifts in how genes are switched on and off, a declining ability of cells to clear away damaged proteins, faltering mitochondria, the build-up of senescent cells that have stopped dividing but keep sending out inflammatory signals, changes in the microbiome, and a low-grade, chronic inflammation that rises with age. These processes belong to no single organ. They unfold in the heart, the kidneys, the blood vessels and the brain at the same time, which helps explain why the diseases they feed so often travel together.

Seen this way, the man in the emergency department carries a single story. The inflammation and metabolic strain that weakened his heart also damaged the small vessels of his brain and wore down the filters of his kidneys. Treating each disease on its own is necessary, and it saves lives every day. The shared process underneath continues all the while.

What slowing the process could mean

The promise of geroscience follows directly. If aging is the common driver, then slowing it even modestly would push back many diseases at once. In 1980, the physician James Fries proposed that medicine aim to compress morbidity, shortening the period of illness and decline at the end of life so that more of life is lived with health and capacity. For most people today that period lasts a decade or longer. Geroscience offers a biological path toward the compression Fries described.

It could also change what a medical trial looks like. The TAME trial (Targeting Aging with Metformin) was designed around this idea. Its investigators proposed testing whether metformin, an inexpensive diabetes drug in use for decades, could delay the onset of several age-related diseases together, with that combined outcome as the measure of success. The trial has been slow to secure full funding, and its answer is still years away. Its design alone marks a shift in how medicine might one day define treatment.

Where the evidence stands

Care is needed here, because this field attracts more confidence than its evidence supports. No drug or supplement has yet been shown to slow human aging. Many of the most striking results come from worms, flies and mice, and the path from those studies to people is long and uncertain. The tools we use to estimate biological age, such as epigenetic clocks, are improving quickly, and they remain better at tracking direction over time than at delivering a verdict on any one person.

We do have strong evidence for a small set of interventions that act on many systems at once. A review of the research across twenty-six chronic diseases found exercise to be an effective treatment or preventive measure for nearly all of them, from heart disease and type 2 diabetes to depression and several cancers. Muscle strength, measured simply by grip, predicted death from any cause and from cardiovascular disease in a study of nearly 140,000 adults across seventeen countries. Restorative sleep, steady metabolic health and close relationships each carry benefits that reach well beyond any one organ.

These are among the oldest recommendations in medicine, and geroscience gives them new weight. They are some of the few levers we know of that reach the common soil.

Practicing with the whole process in view

This understanding shapes how we work at HAYA Precision. We read inflammation, metabolic health, cardiovascular risk, fitness, strength and cognition as parts of one picture, and we follow how that picture changes over time. When we find early strain in one system, we ask what it tells us about the others. The aim is to tend the process before any single disease takes root, and to measure whether the work is moving it.

In my practice, I see how much becomes possible when people understand their health as connected in this way. A person who begins strength training for a sore back may find their blood sugar improving, their sleep deepening and their mood lifting, and the biology of aging helps explain why.

More years, and what they are for

What gives me hope is more than the prospect of additional years. It is the prospect of years lived with capacity, the energy and clarity and presence that let a person keep contributing to the people and the work that need them.

The science, though, answers only half of the question. It can give us more years; what those years are in service of is ours to answer.

Sources

Naisohn Arfai, MD

Physician-led longevity medicine

Learn more →

Continue reading

Interested in exploring whether HAYA Precision is right for you?